drugset / Trial / NCT00143676

Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia

NCT00143676

Phase 3 Completed 448 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the efficacy of lapaquistat acetate, once daily (QD), on lowering cholesterol in subjects already taking atorvastatin.

Timeline

Start
2005-08
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lapaquistat acetate Small molecule 50 mg Oral
Subject Lapaquistat acetate Small molecule 100 mg Oral
Comparator Atorvastatin Small molecule Oral

Indications